You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Amneal Pharmaceuticals, LLCFDAMed source confidence · 80%Jun 26, 2026, 7:06 AM UTC · 12d ago

Amneal Pharmaceuticals, LLC — FDA Class III (D-0585-2026)

Case File

Amneal Pharmaceuticals, LLC is recalling 27,936 bottles of a human prescription drug due to cross-contamination. This recall is classified as a safety issue. The affected products are identified by NDC numbers 53746-544 and 53746-545.

Sign in to follow Amneal Pharmaceuticals, LLC and get alerts like this
Key Points
  • Amneal Pharmaceuticals is recalling 27,936 bottles of a prescription drug.
  • The recall is due to cross-contamination issues.
  • Affected products have NDC numbers 53746-544 and 53746-545.
  • Consumers should check their medicine cabinets for these products.
  • This type of recall has historically weighed on the stock in the near term.
Why This Matters

Consumers with the recalled products should stop using them immediately due to potential contamination. A total of 27,936 bottles are affected.

View original filing →
Sign in to follow Amneal Pharmaceuticals, LLC and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.